{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:58:54Z","timestamp":1791269934025,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jpsychires.2009.10.006","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T10:19:04Z","timestamp":1258021144000},"page":"339-346","source":"Crossref","is-referenced-by-count":116,"title":["Modulation of the mineralocorticoid receptor as add-on treatment in depression: A randomized, double-blind, placebo-controlled proof-of-concept study"],"prefix":"10.1016","volume":"44","author":[{"given":"Christian","family":"Otte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Hinkelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Yassouridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2009.10.006_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/ajp.152.2.265","article-title":"Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial","volume":"152","author":"Arana","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/sj.npp.1300158","article-title":"Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic\u2013pituitary\u2013adrenocortical axis","volume":"28","author":"Bachmann","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0166-2236(95)93942-Q","article-title":"Do antidepressants stabilize mood through actions on the hypothalamic\u2013pituitary\u2013adrenocortical system?","volume":"18","author":"Barden","year":"1995","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0006-3223(02)01432-4","article-title":"An open label trial of C-1073 (mifepristone) for psychotic major depression","volume":"52","author":"Belanoff","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2008.07071199","article-title":"A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression","volume":"165","author":"Binneman","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0091-3057(98)00071-9","article-title":"Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors","volume":"60","author":"Bitran","year":"1998","journal-title":"Pharmacology Biochemistry and Behaviour"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0002-9343(03)00182-7","article-title":"Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study","volume":"114","author":"Blockmans","year":"2003","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1172\/JCI115086","article-title":"Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications","volume":"87","author":"Brady","year":"1991","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib9","doi-asserted-by":"crossref","unstructured":"Brinks V, vanderMark M, deKloet E, Oitzl MS. Differential MR\/GR activation in mice results in emotional states beneficial or impairing for cognition. Neural Plasticity, 2007 [Article ID 90163].","DOI":"10.1155\/2007\/90163"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.psyneuen.2007.05.016","article-title":"The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic\u2013adrenal\u2013pituitary (HPA) axis activity in healthy controls","volume":"32","author":"Buckley","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib11","unstructured":"Bundesgesundheitsberichterstattung, 2008. <http:\/\/www.gbe-bund.de\/>."},{"key":"10.1016\/j.jpsychires.2009.10.006_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.biopsych.2006.05.034","article-title":"Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression","volume":"60","author":"DeBattista","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib14","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1176\/appi.ajp.157.8.1334","article-title":"Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study","volume":"157","author":"DeBattista","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ncpendmet0403","article-title":"Therapy Insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?","volume":"3","author":"deKloet","year":"2007","journal-title":"Nature Clinical Practice Endocrinology and Metabolism"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib16","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-3223(99)00189-4","article-title":"PET imaging of serotonin 1A receptor binding in depression","volume":"46","author":"Drevets","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib17","doi-asserted-by":"crossref","unstructured":"Gallagher P, Malik N, Newham J, Young AH, Ferrier IN, Mackin P. Antiglucocorticoid treatments for mood disorders. Cochrane Database of Systematic Reviews, 2008, CD005168.","DOI":"10.1002\/14651858.CD005168.pub2"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4088\/JCP.v69n1001","article-title":"The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies","volume":"69","author":"Gelenberg","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib19","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1523\/JNEUROSCI.21-13-04822.2001","article-title":"Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone","volume":"21","author":"Gesing","year":"2001","journal-title":"Journal of Neurosciences"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/eje.0.1510397","article-title":"Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties","volume":"151","author":"Grossmann","year":"2004","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yhbeh.2008.02.004","article-title":"Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior","volume":"54","author":"Hlavacova","year":"2008","journal-title":"Hormones and Behaviour"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-3956(98)90056-5","article-title":"The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety","volume":"33","author":"Holsboer","year":"1999","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejphar.2007.12.032","article-title":"Central CRH system in depression and anxiety \u2013 evidence from clinical studies with CRH1 receptor antagonists","volume":"583","author":"Holsboer","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib24","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1001\/jama.289.23.3167","article-title":"Research on major depression: strategies and priorities","volume":"289","author":"Insel","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archpsyc.61.12.1235","article-title":"Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial","volume":"61","author":"Jahn","year":"2004","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejphar.2007.11.064","article-title":"Functional actions of corticosteroids in the hippocampus","volume":"583","author":"Joels","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tins.2007.10.005","article-title":"The coming out of the brain mineralocorticoid receptor","volume":"31","author":"Joels","year":"2008","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00213-006-0555-4","article-title":"Different responses to dexamethasone and prednisolone in the same depressed patients","volume":"189","author":"Juruena","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib29","article-title":"Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series","author":"Juruena","year":"2008","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1192\/bjp.bp.108.050278","article-title":"Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance","volume":"194","author":"Juruena","year":"2009","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib31","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1001\/jama.289.23.3152","article-title":"Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond","volume":"289","author":"Keller","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejphar.2007.07.072","article-title":"Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy","volume":"583","author":"Kellner","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4530(94)00069-7","article-title":"Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze","volume":"20","author":"Korte","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib34","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.npp.1301260","article-title":"Mental performance in old age dependent on cortisol and genetic variance in the mineralocorticoid and glucocorticoid receptors","volume":"32","author":"Kuningas","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib35","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1460-9568.2007.05427.x","article-title":"Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia","volume":"25","author":"Lai","year":"2007","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib36","first-page":"173S","article-title":"Glucocorticoid and mineralocorticoid receptor mRNA levels in the hippocampus and prefrontal cortex of subjects with mood disorders and schizophrenia","volume":"53","author":"Lopez","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0006-3223(97)00484-8","article-title":"Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression","volume":"43","author":"Lopez","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/YIC.0b013e3282eff7e0","article-title":"Which antidepressants have demonstrated superior efficacy? A review of the evidence","volume":"22","author":"Montgomery","year":"2007","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-244X-3-15","article-title":"The Renin\u2013Angiotensin\u2013Aldosterone system in patients with depression compared to controls \u2013 a sleep-endocrine study","volume":"3","author":"Murck","year":"2003","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib40","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1176\/ajp.154.11.1497","article-title":"DST studies in psychotic depression: a meta-analysis","volume":"154","author":"Nelson","year":"1997","journal-title":"American Journal of Psychiatry"},{"issue":"Suppl.","key":"10.1016\/j.jpsychires.2009.10.006_bib41","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/nn943","article-title":"Treatment of mood disorders","volume":"5","author":"Nemeroff","year":"2002","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib42","unstructured":"NIMH. Breaking ground, breaking through: the strategic plan for mood disorders research of the National Institute of Mental Health. 2003. <http:\/\/www.nimh.nih.gov\/strategic\/mooddisorders.pdf>."},{"key":"10.1016\/j.jpsychires.2009.10.006_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-0528.1979.tb10582.x","article-title":"Treatment of premenstrual syndrome by spironolactone","volume":"86","author":"O\u2019Brien","year":"1979","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib44","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0024-3205(03)00513-7","article-title":"The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone","volume":"73","author":"Otte","year":"2003","journal-title":"Life Sciences"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.npp.1301217","article-title":"Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition","volume":"32","author":"Otte","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib46","doi-asserted-by":"crossref","first-page":"B900","DOI":"10.1093\/gerona\/58.10.B900","article-title":"Mineralocorticoid receptor-mediated inhibition of the hypothalamic\u2013pituitary\u2013adrenal axis in aged humans","volume":"58","author":"Otte","year":"2003","journal-title":"Journal of Gerontology A: Biological Sciences and Medical Sciences"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib48","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archpsyc.57.8.755","article-title":"24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression","volume":"57","author":"Posener","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib49","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/en.133.1.312","article-title":"Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic\u2013pituitary\u2013adrenocortical system","volume":"133","author":"Reul","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.285.1.52","article-title":"Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial","volume":"285","author":"Rowe","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib51","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1073\/pnas.0606067104","article-title":"Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice","volume":"104","author":"Rozeboom","year":"2007","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib52","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejphar.2008.01.001","article-title":"Glucocorticoid antagonists in neuropsychiatric disorders","volume":"583","author":"Schatzberg","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1159\/000126180","article-title":"Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo","volume":"55","author":"Seckl","year":"1992","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib54","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0091-3057(96)00244-4","article-title":"Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats","volume":"56","author":"Smythe","year":"1997","journal-title":"Pharmacology Biochemistry and Behaviour"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib55","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00016349509021201","article-title":"Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study","volume":"74","author":"Wang","year":"1995","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib56","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/mp.2008.38","article-title":"Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances","volume":"13","author":"Wang","year":"2008","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib57","first-page":"33","article-title":"\u00dcberraschende Wirkungen von Spironolacton auf Essverhalten und Befindensparameter bei Bulimie","volume":"7","author":"Wernze","year":"2000","journal-title":"Psychopharmakotherapie"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib58","unstructured":"WHO, 2007. <http:\/\/www.who.int\/whosis\/whostat2007_10highlights.pdf>."},{"key":"10.1016\/j.jpsychires.2009.10.006_bib59","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0006-3223(98)00267-4","article-title":"Antiglucocorticoid treatment of depression: double-blind ketoconazole","volume":"45","author":"Wolkowitz","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0169-328X(02)00418-7","article-title":"The effect of chronic fluoxetine treatment on brain corticosteroid receptor mRNA expression and spatial memory in young and aged rats","volume":"106","author":"Yau","year":"2002","journal-title":"Brain Research and Molecular Brain Research"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(01)01890-0","article-title":"Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus","volume":"306","author":"Yau","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0306-4522(94)00612-9","article-title":"Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats","volume":"66","author":"Yau","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archpsyc.60.1.24","article-title":"Mineralocorticoid receptor function in major depression","volume":"60","author":"Young","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.10.006_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3956(00)00016-9","article-title":"Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated","volume":"34","author":"Zobel","year":"2000","journal-title":"Journal of Psychiatric Research"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395609002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395609002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T15:54:06Z","timestamp":1710690846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395609002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0022395609002295"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2009.10.006","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}